Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

439 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 439 results

Testing effectiveness (Phase 2)Study completedNCT03298815
What this trial is testing

Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

Who this might be right for
Ocular Graft Versus Host Disease
University of Utah 15
Testing effectiveness (Phase 2)Study completedNCT05311514
What this trial is testing

Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease

Who this might be right for
Ocular Graft-versus-host Disease
St. Petersburg State Pavlov Medical University 38
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Early research (Phase 1)Study completedNCT02318082
What this trial is testing

Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD

Who this might be right for
Chronic Versus Graft Host Disease
Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)WithdrawnNCT01028313
What this trial is testing

Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-Versus-Host Disease
SCRI Development Innovations, LLC
Testing effectiveness (Phase 2)Ended earlyNCT04232397
What this trial is testing

Anlotinib Treatment in Steroid Depenent/Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5
Not applicableStudy completedNCT00619879
What this trial is testing

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Who this might be right for
Leukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 81
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Early research (Phase 1)Study completedNCT05873907
What this trial is testing

Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants

Who this might be right for
Chronic Graft-versus-host Disease (cGVHD)
Amgen 64
Testing effectiveness (Phase 2)Ended earlyNCT04446182
What this trial is testing

Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD

Who this might be right for
Chronic Graft-versus-host-disease
University of Utah 3
Early research (Phase 1)Active Not RecruitingNCT01937468
What this trial is testing

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft Versus Host DiseaseChronic GVHDComplications of Organ Transplant Stem Cells
Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)UnknownNCT03357159
What this trial is testing

Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation

Who this might be right for
Graft Versus Host Disease
Sheba Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02066051
What this trial is testing

IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD

Who this might be right for
GVHDOcular RosaceaDry Eye Syndrome
Mayo Clinic 8
Testing effectiveness (Phase 2)Looking for participantsNCT04959175
What this trial is testing

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Who this might be right for
Hematologic Neoplasms
National Cancer Institute (NCI) 320
Testing effectiveness (Phase 2)Study completedNCT02891395
What this trial is testing

Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host

Who this might be right for
Graft Versus Host Disease
University Hospital, Lille 65
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT00210912
What this trial is testing

The Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 328
Not applicableApproved For MarketingNCT05722912
What this trial is testing

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Load More Results